A child with an ultra-rare progressive neurodegenerative disorder received an individualised gene therapy in a single-patient clinical trial at the Hospital for Sick Children, affiliated with the University of Toronto, Canada, in March 2022.
The findings published in Nature, show that the gene therapy halted the progression of the condition.
Genetic Engineering and Biotechnology News has more information.